Yazdan Yazdanpanah is currently the head of an Inserm team on decision analysis in Infectious Diseases, the Head of Infectious Disease department at Bichat Claude Bernard Hospital, and Professor of Medicine at Paris Diderot University, France. Yazdan Yazdanpanah became an MD from the Lille School of Medicine, France in 1996.
He qualified from the same institution first as a hepato- gastro-enterologist in 1996 and next an infectious disease specialist in 2002. He obtained a Master of Science degree in epidemiology from the Harvard School of Public Health, Boston, US in 2000, and a Ph.D degree in public health from the Bordeaux School of Public Health in 2002. In 2006, he became Professor of Infectious Disease. His research interests include the clinical epidemiology of HIV and viral hepatitis, and the pharmaco-economics of antimicrobial agents.
He is one of the coordinators of Inserm REACTing, a network under the umbrella of Aviesan (REsearch and ACTion targeting emerging infectious disease) the goal of which is to optimize and coordinate the existing research capacities during emerging and re-emerging infection threats. In February 2017, he was appointed Director of the French Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology and The Chair of the Global Research Collaboration for Infectious Disease Preparedness International Network. In May 2019, he was appointed The Chair of The European & Developing Countries Clinical Trials Partnership (EDCTP) board. Professor Yazdanpanah has published extensively in peer-reviewed journals and makes frequent presentations at numerous national and international meetings.
